Policy Summit

States Innovating on Gene Therapy Medicaid Reimbursement

ASGCT Staff | November 12, 2019

During the November 5 program at the ASGCT Policy Summit in Washington, D.C., state Medicaid experts shared their perspectives on developing coverage for these innovative new treatments.

Policy Summit
Read Full Story

Government Innovation is Key to Creating Regulatory Convergence

ASGCT Staff | November 11, 2019

During the Policy Summit’s Nov. 4 session, Developments in Gene Therapy Policy Landscape, speakers emphasized the importance of balancing predictability with flexibility as they discussed ways to align regulatory frameworks for gene and cell therapies.

Policy Summit
Read Full Story

NIH’s Collins Calls for Germline Gene Editing Moratorium at Policy Summit

ASGCT Staff | November 06, 2019

NIH Director Francis Collins, M.D., Ph.D. called for a worldwide moratorium on clinical uses of human germline gene editing, while defending ongoing and future applications of therapeutic somatic gene editing, on the third day of the ASGCT Policy Summit on November 6. 

Policy Summit
Read Full Story

New Payment Solutions Presented at ASGCT Policy Summit Could Help Offset Costs of Gene and Cell Therapies

ASGCT Staff | November 06, 2019

Speakers on the second day of the ASGCT Policy Summit discussed innovative payment strategies that they believe will help offset the cost of gene therapies and ensure more people gain access to these treatments.

Policy Summit
Read Full Story

FDA's Marks Urges International Collaboration at ASGCT Policy Summit

ASGCT Staff | November 05, 2019

Now is the time, Marks said during his keynote address, for regulators to work towards a globally harmonized framework that will facilitate the safe and ethical development of transformative gene therapy products. 

Policy Summit
Read Full Story

Register by Oct. 28 for the ASGCT Policy Summit

ASGCT Staff | October 24, 2019

Join us in Washington, D.C. for discussions about global regulatory, payment policy, and ethical issues surrounding gene therapy. 

Policy Summit
Read Full Story

ASGCT Policy Summit Highlights Patient and Advocate Perspectives

ASGCT Staff | October 14, 2019

ASGCT will have patient, caregiver, and advocate speakers participating in all three days of our upcoming Policy Summit, held at The Westin in Washington, D.C. November 4-6.

Advocacy   |   Policy Summit
Read Full Story

FDA photo

Margaret Hamburg, M.D. to Speak at Policy Summit

ASGCT Staff | September 26, 2019

Margaret Hamburg, M.D., an internationally recognized expert in medicine and public health, will be one of the keynote speakers on November 6, the third and final day of the ASGCT Policy Summit in Washington, D.C.

 

Education   |   Policy Summit   |   Policy Updates
Read Full Story

Credit: Daniel Soñé Photography, LLC

NIH Director Collins to Speak at ASGCT Policy Summit

ASGCT Staff | September 05, 2019

Francis Collins, M.D., Ph.D., director of the National Institutes of Health, will deliver his keynote address, "The Need for an International Moratorium on Clinical Uses of Human Germline Gene Editing," on day three of the ASGCT Policy Summit, November 6.

Education   |   Policy Summit   |   Policy Updates
Read Full Story
2020

23rd Annual Meeting

May 12-15 | Boston